These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21813424)

  • 21. Diminishing returns...and too many choices...the saga of pharmacologic therapy to reduce the complications of percutaneous coronary intervention.
    Stadius ML
    J Am Coll Cardiol; 2004 Jul; 44(1):25-7. PubMed ID: 15234400
    [No Abstract]   [Full Text] [Related]  

  • 22. Abnormal troponin I levels during pregnancy without acute coronary syndrome and without hypertensive disorders.
    Patanè S; Marte F; Di Bella G; Davi' M
    Int J Cardiol; 2008 Aug; 128(2):e47-9. PubMed ID: 17544531
    [No Abstract]   [Full Text] [Related]  

  • 23. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.
    Wilson SR; Sabatine MS; Braunwald E; Sloan S; Murphy SA; Morrow DA
    Am Heart J; 2009 Sep; 158(3):386-91. PubMed ID: 19699861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
    Bonaca M; Scirica B; Sabatine M; Dalby A; Spinar J; Murphy SA; Jarolim P; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2010 May; 55(19):2118-24. PubMed ID: 20447535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute coronary syndrome in acute stroke].
    Jansen F; Nickenig G; Petzold GC; Werner N
    Med Klin Intensivmed Notfmed; 2017 Feb; 112(1):4-10. PubMed ID: 26502408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the 30-day rate of adverse cardiac events in chest pain patients with ED troponin I assays≤99th centile using a contemporary sensitive assay? An exploratory analysis.
    Kelly AM; Klim S
    Eur J Emerg Med; 2014 Aug; 21(4):276-80. PubMed ID: 24025851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36.
    Bonaca MP; O'Malley RG; Murphy SA; Jarolim P; Conrad MJ; Braunwald E; Sabatine MS; Morrow DA
    Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):431-40. PubMed ID: 25538086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes associated with small changes in normal-range cardiac markers.
    McMullin N; Lindsell CJ; Lei L; Mafi J; Jois-Bilowich P; Anantharaman V; Pollack CV; Hollander JE; Gibler WB; Hoekestra JW; Diercks D; Peacock WF;
    Am J Emerg Med; 2011 Feb; 29(2):162-7. PubMed ID: 20825781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].
    Silber S; Helms TM; Garlichs C; Arntz HR; Weil J; Ince H; Klingenheben T; Hoffmann S; Boudriot E; Steiger H; Zugck C
    Dtsch Med Wochenschr; 2011 Apr; 136(15):782-5. PubMed ID: 21432747
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of acute coronary syndromes.
    Tahiliani N; Trivedi A; Deshmukh HG
    N Engl J Med; 2002 Jan; 346(3):206-8. PubMed ID: 11797722
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
    Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients?
    Anders B; Alonso A; Artemis D; Schäfer A; Ebert A; Kablau M; Fluechter S; Findeisen P; Hennerici MG; Fatar M
    Cerebrovasc Dis; 2013; 36(3):211-7. PubMed ID: 24135532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disrupting Common Practice: Retiring Stress Tests for Acute Chest Pain Presentations.
    Contractor J; Choi JJ
    Mayo Clin Proc; 2020 Nov; 95(11):2356-2359. PubMed ID: 33153627
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection and management of asymptomatic myocardial injury after noncardiac surgery.
    van Klei WA; Grobbee DE; Grobben RB; van Waes JA; Nathoe HM
    Eur J Prev Cardiol; 2013 Dec; 20(6):918-21. PubMed ID: 24169590
    [No Abstract]   [Full Text] [Related]  

  • 36. Approaching 2020 acuity for high-sensitivity cardiac troponin assays in Clinical Biochemistry.
    Kavsak PA
    Clin Biochem; 2020 Apr; 78():1-3. PubMed ID: 31991127
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and efficacy of policosanol in patients with high on-treatment platelet reactivity after drug-eluting stent implantation: two-year follow-up results.
    Xu K; Liu X; Li Y; Wang Y; Zang H; Guo L; Wang Y; Zhao W; Wang X; Han Y
    Cardiovasc Ther; 2016 Oct; 34(5):337-42. PubMed ID: 27328023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute coronary syndrome: technological improvements in diagnostics and therapy].
    Verheugt FW
    Ned Tijdschr Geneeskd; 1999 Nov; 143(45):2241-6. PubMed ID: 10578422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome.
    Cullen L; Mueller C; Parsonage WA; Wildi K; Greenslade JH; Twerenbold R; Aldous S; Meller B; Tate JR; Reichlin T; Hammett CJ; Zellweger C; Ungerer JPJ; Rubini Gimenez M; Troughton R; Murray K; Brown AFT; Mueller M; George P; Mosimann T; Flaws DF; Reiter M; Lamanna A; Haaf P; Pemberton CJ; Richards AM; Chu K; Reid CM; Peacock WF; Jaffe AS; Florkowski C; Deely JM; Than M
    J Am Coll Cardiol; 2013 Oct; 62(14):1242-1249. PubMed ID: 23583250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clopidogrel, genetics, and drug responsiveness.
    Freedman JE; Hylek EM
    N Engl J Med; 2009 Jan; 360(4):411-3. PubMed ID: 19164193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.